1. Home
  2. ADMA vs ENS Comparison

ADMA vs ENS Comparison

Compare ADMA & ENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • ENS
  • Stock Information
  • Founded
  • ADMA 2004
  • ENS 1991
  • Country
  • ADMA United States
  • ENS United States
  • Employees
  • ADMA N/A
  • ENS N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • ENS Industrial Machinery/Components
  • Sector
  • ADMA Health Care
  • ENS Technology
  • Exchange
  • ADMA Nasdaq
  • ENS Nasdaq
  • Market Cap
  • ADMA 3.7B
  • ENS 3.4B
  • IPO Year
  • ADMA N/A
  • ENS N/A
  • Fundamental
  • Price
  • ADMA $15.05
  • ENS $119.75
  • Analyst Decision
  • ADMA Strong Buy
  • ENS Strong Buy
  • Analyst Count
  • ADMA 3
  • ENS 2
  • Target Price
  • ADMA $27.67
  • ENS $117.50
  • AVG Volume (30 Days)
  • ADMA 3.1M
  • ENS 354.4K
  • Earning Date
  • ADMA 11-06-2025
  • ENS 11-05-2025
  • Dividend Yield
  • ADMA N/A
  • ENS 0.86%
  • EPS Growth
  • ADMA 469.09
  • ENS 32.64
  • EPS
  • ADMA 0.85
  • ENS 8.77
  • Revenue
  • ADMA $474,174,000.00
  • ENS $3,657,687,000.00
  • Revenue This Year
  • ADMA $21.17
  • ENS $2.83
  • Revenue Next Year
  • ADMA $26.03
  • ENS $3.01
  • P/E Ratio
  • ADMA $17.41
  • ENS $13.98
  • Revenue Growth
  • ADMA 43.58
  • ENS 3.73
  • 52 Week Low
  • ADMA $13.50
  • ENS $76.57
  • 52 Week High
  • ADMA $25.67
  • ENS $124.84
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 47.74
  • ENS 58.92
  • Support Level
  • ADMA $14.35
  • ENS $119.86
  • Resistance Level
  • ADMA $15.60
  • ENS $124.47
  • Average True Range (ATR)
  • ADMA 0.52
  • ENS 3.84
  • MACD
  • ADMA 0.13
  • ENS 0.24
  • Stochastic Oscillator
  • ADMA 65.17
  • ENS 67.86

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

Share on Social Networks: